Back to search

Article

Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization Protocols

2026-05-21

Abstract excerpt

<title>Abstract</title> <p>Background Hypersensitivity reactions (HSRs) to antineoplastic agents frequently complicate optimal cancer care. This study evaluated the clinical characteristics of patients experiencing Grade ≥ 2 HSRs and compared the efficacy and safety of a simplified single-bag (1-bag) desensitization protocol with the standard three-bag (3-bag) protocol. Methods We analyzed 84 independent episod...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
acd4fb8a-a27e-5351-823c-f1c1cfdc87c0
DOI
10.21203/rs.3.rs-9707882/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization ProtocolsDOI 10.21203/rs.3.rs-9707882/v1
From acute phase mediators to drug provocation testing: a single center experience in the allergy work-up of adverse drug reactions to chemotherapySemantic proximity
A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.Semantic proximity
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: phenotypes, endotypes and management with desensitization.Semantic proximity
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.Semantic proximity
Management of adverse reactions to biologic agents.Semantic proximity
Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.Semantic proximity
The Increasing Role of the Allergist in the Management of Infusion Reactions at the Oncology Day HospitalSemantic proximity
Association between the use of individual beta-lactam antibiotics and neuromuscular blocking agents on the incidence of perioperative hypersensitivity in cancer patients: an 8-year single-center retrospective studySemantic proximity
Biologic Treatment for Cutaneous Immune-Related Adverse Events in Cancer Patients Undergoing Immune-Checkpoint Therapy: A Retrospective ReviewSemantic proximity
Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity
Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers.Semantic proximity
Infusion-Related Reaction Management With Amivantamab for EGFR Exon 20 Insertion Mutation NSCLC: A Practical Guide for Advanced PractitionersSemantic proximity
Select a neighboring publication to make it the new centre.